Acquisitions

9 Months Ended

Dec. 31, 2024

Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]

Acquisitions

Note 14 – Acquisitions

Mister Meds was acquired for a total of $54,220 on October 1, 2024, and Avenvi, LLC acquired for $1,058,788, total consideration and assets acquired between the two entities was $1,113,008, which included a $400,000 short term loan. The Company followed the guidelines under ASC 805, Business Combinations, the transaction was accounted for as asset acquisition, no goodwill was recognized from the transactions, since the fair value of the assets was the purchase price for both entities.

Mister Meds is in the process of obtaining full licensure as a compounding pharmacy. The company is projected to begin operations in the first quarter of 2025. The pharmacy will feature a state-of-the-art sterile room, equipped with both positive and negative pressure capabilities, as well as hazardous compounding facilities. It will operate from a 5,000 sq. ft. facility owned by Avenvi LLC, a related party. Additionally, Mister Meds plans to apply for state licenses in markets where RxCompoundStore.com is not yet licensed.

Avenvi is a diversified company with expertise across various segments of the real estate industry. The company has developed a robust portfolio of real estate assets, primed for development, and provides financing solutions to purchasers of properties developed by Avenvi. This strategic positioning allows Avenvi to engage in the real estate market at every stage, from identifying development opportunities to facilitating end-user property acquisitions. In addition, Avenvi manages investments for ETST and oversees the ongoing $5 million share repurchase program.

Assets acquired from Avenvi LLC and Mister Meds.

Cash	$	295,760
Investments		186,824
Property and equipment		600,951
Intangibles assets		29,473
Total assets acquired	$	1,113,008
Purchase price	$	1,113,008